Trevi Therapeutics Inc

NASDAQ:TRVI   3:59:50 PM EDT
1.35
-0.10 (-6.90%)
Other Pre-Announcement

Trevi Therapeutics Announces Second Quarter 2021 Financial Results And Business Update

Published: 08/12/2021 22:11 GMT
Trevi Therapeutics Inc (TRVI) - Trevi Therapeutics Announces Second Quarter 2021 Financial Results and Business Update.
Trevi Therapeutics Inc - Phase 2 Canal (chronic Cough in Ipf) Trial Recruiting, Top-line Data Readout Expected First Half of 2022.
Trevi Therapeutics - As of June 30, 2021, Total Cash, Equivalents of $36.4 Million, Versus $45.0 Million As of December 31, 2020.